Skip to main content

Table 6 Common CLU associations with AD.

From: Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk

(A) Allelic associations in stage I and II AD cohorts

         
  

Belgian-Flanders

  

Lille

   

Toronto

   
 

Allele

AD (total)

C (total)

OR [95% CI]

p

AD (total)

C (total)

OR [95% CI]

p

AD (total)

C (total)

OR [95% CI]

p

rs867230

T

0.63 (1259)

0.59 (952)

 

0.074 (1)

0.66 (1736)

0.62 (742)

 

0.022 (1)

0.60 (367)

0.63 (307)

 

0.288 (1)

Intron 1

G

0.37 (752)

0.41 (670)

0.82 [0.70-0.96]

0.012 (2)

0.34 (904)

0.38 (456)

0.89 [0.76-1.04]

0.144 (2)

0.40 (247)

0.37 (181)

1.04 [0.80-1.36]

0.771 (2)

rs1532278

G

0.63 (1308)

0.61 (1006)

 

< 0.01 (1)

0.675 (1789)

0.628 (764)

 

0.004 (1)

0.62 (383)

0.62 (301)

 

0.996 (1)

Intron 3

A

0.37 (770)

0.40 (656)

0.83 [0.71-0.97]

0.019 (2)

0.325 (861)

0.372 (452)

0.83 [0.71-0.97]

0.02 (2)

0.38 (233)

0.38 (183)

1.27 [0.97-1.64]

0.078 (2)

rs11136000

G

0.65 (1232)

0.61 (990)

 

0.034 (1)

0.66 (1707)

0.628 (764)

 

0.195 (1)

0.61 (372)

0.63 (299)

 

0.645 (1)

Intron 3

A

0.35 (676)

0.39 (630)

0.79 [0.68-0.93]

0.004 (2)

0.34 (875)

0.372 (452)

0.93 [0.79-1.10]

0.400 (2)

0.39 (236)

0.37 (179)

1.00 [0.77-1.31]

0.986 (2)

rs9331908

G

0.66 (1389)

0.69 (1161)

 

0.055 (1)

0.62 (1712)

0.66 (841)

 

0.036 (1)

0.66 (416)

0.69 (338)

 

0.297 (1)

Intron 4

A

0.34 (713)

0.31 (521)

1.18 [1.01-1.39]

0.035 (2)

0.38 (1046)

0.35 (443)

1.12 [0.96-1.30]

0.156 (2)

0.34 (214)

0.31 (152)

1.20 [0.91-1.56]

0.198 (2)

rs7982

C

0.63 (1228)

0.61 (1005)

 

0.191 (1)

0.67 (1780)

0.63 (804)

 

0.022 (1)

0.62 (374)

0.60 (295)

 

0.434 (1)

Exon 5

T

0.37 (734)

0.40 (657)

0.85 [0.73-0.99]

0.037 (2)

0.33 (884)

0.37 (470)

0.89 [0.76-1.03]

0.124 (2)

0.38 (234)

0.36 (167)

1.16 [0.89-1.52]

0.273 (2)

(B) Meta-analysis of stage I and II AD cohorts

         
 

Allele

Summary OR

p MH

p Bonf

p woolf'

        

rs867230

T

            

Intron 1

G

0.88 [0.79-0.97]

0.013

0.065

0.311

        

rs1532278

G

            

Intron 3

A

0.85 [0.77-0.94]

0.001

0.005

0.648

        

rs11136000

G

            

Intron 3

A

0.88 [0.79-0.97]

0.013

0.065

0.206

        

rs9331908

G

            

Intron 4

A

1.16 [1.04-1.28]

0.006

0.030

0.824

        

rs7982

C

            

Exon 5

T

0.89 [0.80-0.98]

0.023

0.115

0.448

        
  1. (A) Allele frequencies are shown with absolute numbers in brackets. (1) The first p-value is the 2-sided p-value of the unadjusted χ2 statistics, (2) The second p-value is adjusted for age, APOE status and gender. Calculations of odds ratios (OR), presented with 95% confidence intervals (CI), were performed using the common allele as reference allele. (B) For meta-analysis, Mantel-Haenszel summary OR ratios are given with 95% CI and corresponding p-values (pMH) based on fixed-effects meta-analysis of age, gender and APOE- adjusted effect estimates of the minor allele. Nominal p-values (pmh, adjusted for age, gender and APOE effects) and Bonferroni corrected p-values (p Bonf) for the number of SNPs (N = 5) in the meta-analysis are given. P-values of Woolf's test for heterogeneity (p-woolf) are given.